ArticlePrecision clinical medicine2025
Degree of joint risk factor control and premature mortality in hypertensive participants.
Article in Precision clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multiple Risk Factors Controlled and Mortality Risks in Chronic Kidney Disease.Kidney & blood pressure research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Objective: To investigate whether the excess premature mortality risk related to hypertension could be reduced or eliminated through joint risk factor control. Methods: A total of 70 898 hypertensive participants and 224 069 matched non-hypertensive participants without cancer or cardiovascular disease (CVD) at baseline were included and followed from 2006 to 2022. The degree of joint risk factor control was evaluated based on the major cardiovascular risk factors, including blood pressure, body mass index, waist circumference, low-density lipoprotein cholesterol, glycated haemoglobin, albuminuria, smoking, and physical activity. Cox proportional hazards models were used to investigate the relationship between degree of risk factor control and premature mortality. Results: Each additional risk factor control was associated with a 15%, 12%, 24%, and 11% lower risk of premature all-cause mortality, premature cancer mortality, premature CVD mortality, and premature other mortality, respectively. Optimal risk factor control (≥6 risk factors) was associated with a 55% [hazard ratio (HR): 0.45, 95% confidence interval (CI): 0.40-0.51], 50% (HR: 0.50, 95% CI: 0.41-0.60), 67% (HR: 0.33, 95% CI: 0.26-0.42), and 50% (HR: 0.50, 95% CI: 0.40-0.62) lower risk of premature all-cause mortality, premature cancer mortality, premature CVD mortality, and premature other mortality, respectively. Hypertensive participants with 3, 2, 4, and 2 or more controlled risk factors showed no excess risk of premature all-cause mortality, premature cancer mortality, premature CVD mortality, and premature other mortality, respectively, compared to matched non-hypertensive participants. Conclusions: In this cohort study of UK Biobank participants, degree of joint risk factor control shows gradient inverse association with risk of premature mortality in hypertensive participants; optimal risk factor control may eliminate hypertension-related excess risk of premature mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.